Skip to main content
$9.83 -$0.03 (-0.3%)

04:00 PM EDT on 07/29/21

Co-Diagnostics, Inc. (NASDAQ:CODX)

CAPS Rating: 1 out of 5

Current Price $9.83 Mkt Cap $284.8M
Open $9.97 P/E Ratio 5.40
Prev. Close $9.83 Div. (Yield) $0.00 (0.0%)
Daily Range $9.63 - $10.15 Volume 646,931
52-Wk Range $7.01 - $30.99 Avg. Daily Vol. 1,240,554

Caps

How do you think NASDAQ:CODX will perform against the market?

Add Stock to CAPS Watchlist

All Players

34 Outperform
36 Underperform
 

All-Star Players

8 Outperform
22 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CODX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

peacemaker01 (64.96)
Submitted April 19, 2020

CODX is a frontrunner in diagnostic tests for covid19.

joaquingrech (97.40)
Submitted March 27, 2020

it may surge now but long term i just don't see it, only 1 product and easy to replicate

NASDAQ:CODX VS S&P 500 (SPY)

NASDAQ:CODX Summary

Fools bullish on NASDAQ:CODX are also bullish on:

Fools bearish on NASDAQ:CODX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CODX.

Recs

0
Member Avatar BuyouTech (< 20) Submitted: 5/13/2021 5:42:16 PM : Outperform Start Price: $7.49 NASDAQ:CODX Score: +30.22

Tiny $200M market cap biotech that is already profitable. No debt and 50% margins. Has patented co-primer technology that works with both DNA and RNA. Approx. 50% International sales of Covid 19 PCR test. Pursuing a broad range of clinical testing possibilities including liquid biopsy cancer detection and direct to consumer Covid testing.

Recs

0
Member Avatar Kentuckyfarmer (56.79) Submitted: 1/15/2021 7:22:08 AM : Outperform Start Price: $10.13 NASDAQ:CODX Score: -19.92

Increased revenue in 2020 was due to covid-19 testing and that was just what the company needed to finally become profitable. They have many other test capabilities if Covid-19 tests go away. They are also involved in the agricultural field which is another interesting avenue for growth in the future. Small cap with lots of room to run

Recs

0
Member Avatar TMFjbonefish (67.09) Submitted: 1/12/2021 7:09:04 PM : Outperform Start Price: $10.42 NASDAQ:CODX Score: -22.01

Intellectual property that results in better product performance in a fast-growing competitive space is a recipe for getting acquired or being in a position to take share from others. Applications in agriculture are also intriguing.

Leaderboard

Find the members with the highest scoring picks in CODX.

Score Leader

copetom

copetom (38.58) Score: +426.68

Due to the panic over covid-19 I marked it as outperform. Which it did for a few days. I have since sold it, NVAX, INO, and 2 others. Nice profit on NVAX especially.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
OklaBoston 64.50 1/29/2020 Outperform 3Y $2.34 +320.09% +34.46% +285.63 2 Comments
Toprope101 99.71 3/12/2020 Underperform 5Y $12.76 -22.96% +72.13% +95.09 0 Comment
Halffrenzy 24.31 5/20/2020 Underperform 5Y $18.43 -46.66% +47.98% +94.65 0 Comment
NorteClub 33.14 7/29/2020 Underperform 5Y $22.14 -55.60% +36.80% +92.40 0 Comment
RayNobleEsq 99.93 4/21/2020 Underperform 5Y $13.46 -26.97% +60.32% +87.29 0 Comment
ClientNein 99.44 7/17/2020 Underperform 5Y $17.75 -44.62% +36.91% +81.53 0 Comment
dinasourneil 98.95 3/6/2020 Underperform 1Y $14.23 -30.92% +50.40% +81.32 0 Comment
TMFGBudwell 68.71 2/27/2020 Outperform 5Y $4.42 +122.40% +44.39% +78.01 0 Comment
chrispycrunch 85.13 3/5/2020 Underperform 5Y $14.65 -32.90% +44.65% +77.55 0 Comment
jackbot 94.36 6/5/2020 Underperform 5Y $15.83 -37.90% +37.41% +75.31 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CODX.